Chapter 9

*Advances in Rehabilitation of Hearing Loss*

Yperman M, Daemers K, Offeciers FE, O'Donoghue GM, et al. Long-term evaluation of the effect of intracochlear Multicenter clinical trial of the nucleus hybrid S8 cochlear implant: Final outcomes. The Laryngoscope.

[76] Chiossi JSC, Hyppolito MA. Effects

systematic-review. International Journal of Pediatric Otorhinolaryngology.

of residual hearing on cochlear implant outcomes in children: A

2016;**126**(4):962-973

2017;**100**:119-127

[68] De Ceulaer G, Johnson S,

steroid deposition on electrode impedance in cochlear implant patients. Otology and Neurotology.

[69] Liu Y, Jolly C, Braun S, Stark T, Scherer E, Plontke SK, et al. In vitro and in vivo pharmacokinetic study of a dexamethasone-releasing silicone for cochlear implants. European Archives of Oto-Rhino-Laryngology.

2003;**24**(5):769-774

2016;**273**(7):1745-1753

2018;**13**(3):e0195230

2013;**14**(1):45-50

HNO. 2017;**65**(1):19-28

2013;**34**(4):667-674

[75] Gantz BJ, Dunn C, Oleson J, Hansen M, Parkinson A, Turner C.

[70] Lyu AR, Kim DH, Lee SH, Shin DS, Shin SA, Park YH. Effects of dexamethasone on intracochlear inflammation and residual hearing after cochleostomy: A comparison of administration routes. PLoS One.

[71] Farhadi M, Jalessi M, Salehian P, Ghavi FF, Emamjomeh H, Mirzadeh H, et al. Dexamethasone eluting cochlear implant: Histological study in animal model. Cochlear Implants International.

[72] Plontke SK, Götze G, Rahne T, Liebau A. Intracochlear drug delivery in combination with cochlear implants.

[73] Carlson ML, Patel NS, Tombers NM, DeJong MD, Breneman AI, Neff BA, et al. Hearing preservation in pediatric cochlear implantation. Otology and Neurotology. 2017;**38**(6):e128-e133

[74] Havenith S, Lammers MJ, Tange RA, Trabalzini F, della Volpe A, van der Heijden GJ, et al. Hearing preservation surgery: Cochleostomy or round window approach? A systematic review. Otology and Neurotology.

**140**
